Losartas 25 Tablet contains Losartan 25 mg, an angiotensin II receptor antagonist used primarily for the management of hypertension. By selectively blocking the binding of angiotensin II to the AT1 receptor, Losartan promotes vasodilation, thereby reducing peripheral vascular resistance and lowering blood pressure. This mechanism helps prevent complications associated with hypertension such as stroke, myocardial infarction, and kidney damage. Losartas 25 is also indicated for the treatment of diabetic nephropathy in patients with type 2 diabetes and hypertension, as it helps reduce proteinuria and slow progression of renal impairment. The tablet is administered orally, with dosage individualized based on patient response and clinical condition. Common side effects may include dizziness, fatigue, and upper respiratory infections, while serious adverse reactions are rare but can include hyperkalemia and renal dysfunction. Losartas 25 should be used cautiously in patients with impaired liver or kidney function and is contraindicated during pregnancy due to the risk of fetal toxicity. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during therapy. This medication should be used under medical supervision to ensure optimal therapeutic outcomes and minimize potential risks.